Financial
News release
TopTOKYO, JAPAN - September 28, 2017 - Terumo Corporation (TSE: 4543) announced today that its new Innovation Center of its neurovascular and endovascular intervention businesses has opened on September 25th in California, United States.
The facility consolidates Terumo's Neurovascular Division's finance and administrative functions, global marketing and sales activities, research and development center and manufacturing, including a state-of-the-art neuroradiology imaging lab. The area of the complex is nearly doubled and is expected to support its business growth in the rapidly growing neurovascular market.
The Neurovascular Division has been developing some endovascular products for Terumo Interventional Systems Division by leveraging its resources and technologies. The opening of the new Innovation Center accelerates development of therapeutic devices with the aim of launching the products globally.
As a global corporation with unique excellence, Terumo aims to become a top brand trusted in medical settings all over the world through providing "Total Quality": high quality in all aspect of product, supply and service.
About the Innovation Center
| Location | Aliso Viejo, California, United States |
| Business | Development, manufacture, and sale of neurovascular/endovascular intervention |
| Products | Embolization coils, stents for neurovascular, balloon catheters, embolization beads, and many other related products |
| Opening | September, 2017 |
| Site area | 205,000 square feet |
| Employees | More than 800 |
About Terumo
Terumo (TSE: 4543) is a global medical innovation company. Guided by an unwavering commitment to patients, and driven by the passion of our associates, we strive to fulfill our Group Mission of “Contributing to Society through Healthcare.” Founded in Tokyo in 1921, we provide a comprehensive range of solutions in the fields of therapeutic procedures, hospital operations, and life sciences in more than 160 countries and regions.